Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Medical weight management programs provide structured, ongoing care focusing on more than medication alone
European Journal of Anatomy
On average: Semaglutide is associated with about 15 percent body weight loss Liraglutide leads to 5-10 percent weight loss Tirzepatide has resulted in up to 20 percent weight loss in some studies Key points to remember: Research suggests that patients with type 2 diabetes lose on average almost half of the weight loss that is seen for patients without diabetes, in the range of 5-12 percent of their initial weight
However, potential side effects can include: Nausea or dizziness (rare) Headaches Injection site irritation Overstimulation or fatigue if overdosed There are no long-term human trials, so effects on hormones, organs, or chronic use remain unknown
10.1016/j.peptides.2022.170749 14 McCarthyT.GreenB
